berberine has been researched along with Polycystic Ovarian Syndrome in 25 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this one-group pretest-post-test explanatory study was to evaluate, in normal-overweight PCOS women with normal menses, the effectiveness of berberine on: Insulin resistance (IR) by Homeostasis Model Assessment (HOMA); Inflammation by C-Reactive Protein (CRP), Tumor Necrosis Factor α (TNF-α); Lipid metabolism; Sex hormone profile and symptoms correlated to hyperandrogenism, such as acne, by Global Acne Grading System (GAGS) and Cardiff Acne Disability Index (CADI); Body composition by DXA." | 9.41 | Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study. ( Allegrini, P; Bernardinelli, L; Fazia, T; Gasparri, C; Giacosa, A; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2021) |
| "To study whether a combination of berberine and letrozole results in higher live births than letrozole alone in infertile women with polycystic ovary syndrome (PCOS)." | 9.22 | Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. ( Liang, RN; Liu, JP; Ma, HX; Ng, EH; Shao, XG; Wang, YY; Wu, XK; Xue, HY, 2016) |
| " This randomized controlled trial aims to evaluate the efficacy and safety of berberine in the treatment of patients with polycystic ovary syndrome." | 9.22 | The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial. ( Chai, QY; Liu, JP; Ma, HL; Sun, J; Wu, XK; Zhang, K; Zhang, Y; Zhang, YJ, 2016) |
| "Berberine and metformin treatments prior to IVF improved the pregnancy outcome by normalizing the clinical, endocrine and metabolic parameters in PCOS women." | 9.19 | The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. ( An, Y; Guan, Y; Liu, B; Lu, M; Sun, Z; Zhang, Y, 2014) |
| "We postulate that women with PCOS will have improved insulin resistance following berberine administration." | 9.17 | Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial. ( Hou, L; Kuang, H; Li, Y; Ma, H; Ng, EH; Wu, X; Zhang, Y, 2013) |
| "Berberine has been found to exhibit an array of pharmacological activities relating to the lowering of blood glucose and the treatment of polycystic ovarian syndrome (PCOS)." | 7.96 | Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways. ( Fang, J; Li, F; Liu, X; Liu, Z; Shan, Y; Wang, Y; Zhang, N; Zhao, H; Zhuang, L, 2020) |
| "To study the role of selected serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome (PCOS)." | 7.96 | The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. ( Ai, W; Duan, Y; Kuang, H; Li, D; Li, M; Li, W; Liu, S; Liu, X; Shao, M; Wang, Y; Xu, Y, 2020) |
| "To evaluate the effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome." | 7.81 | A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome. ( Chen, X; Li, C; Li, L; Ng, EH; Pan, P; Wu, X; Yang, D, 2015) |
| " In this study, the serum samples of 15 overweight PCOS patients before and after treatment with berberine for three months were collected for clinic biochemical test and metabolomic research." | 7.80 | [Application of metabolomics in treating polycystic ovary syndrome with berberine based on ultra high performance liquid chromatography-mass spectrometry]. ( Hou, L; Li, Y; Xu, G; Zhang, C; Zhang, H; Zhao, X, 2014) |
| "Theca cells with dexamethasone-induced insulin resistance showed defective glucose uptake and excessive testosterone production, both of which were effectively antagonized by berberine." | 7.77 | Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. ( Baillargeon, JP; Han, F; Hou, L; Kuang, H; Li, W; Wang, Y; Wu, X; Zhao, L, 2011) |
| "Berberine (BBR) is an isoquinoline derivative alkaloid extracted from Chinese medicinal herbs that has been used as an insulin sensitizer." | 6.77 | A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. ( Deng, H; Guan, Y; Liang, K; Ma, Y; Sui, M; Wang, A; Wei, W; Zhang, H; Zhang, Y; Zhao, H, 2012) |
| " In conclusion, the use of berberine for PCOS is safe and promising, even if more studies are needed to create a consensus about the dosage of berberine useful for long-term therapy." | 6.66 | Polycystic ovary syndrome management: a review of the possible amazing role of berberine. ( Faliva, MA; Gasparri, C; Infantino, V; Naso, M; Nichetti, M; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M; Spadaccini, D, 2020) |
| "Berberine (BBR) has many pharmacological properties and is used as an insulin sensitizer." | 5.62 | Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis. ( Li, XL; Shen, HR; Xu, X, 2021) |
| "Berberine is a monomer from Chinese herbs such as Coptis chinensis, whose effect on improving ovulation and endometrial receptivity of PCOS is uncertain." | 5.62 | Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. ( Dong, H; Nie, K; Su, H; Tang, Y; Wang, H; Wang, Z; Xu, X, 2021) |
| "Berberine is an isoquinoline plant alkaloid with numerous biological activities, and it was testified to improve some diseases related to PCOS in animal models and in humans." | 5.43 | Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome. ( Fu, X; Kuang, H; Wang, Q; Wang, Y; Xu, J, 2016) |
| " The aim of this one-group pretest-post-test explanatory study was to evaluate, in normal-overweight PCOS women with normal menses, the effectiveness of berberine on: Insulin resistance (IR) by Homeostasis Model Assessment (HOMA); Inflammation by C-Reactive Protein (CRP), Tumor Necrosis Factor α (TNF-α); Lipid metabolism; Sex hormone profile and symptoms correlated to hyperandrogenism, such as acne, by Global Acne Grading System (GAGS) and Cardiff Acne Disability Index (CADI); Body composition by DXA." | 5.41 | Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study. ( Allegrini, P; Bernardinelli, L; Fazia, T; Gasparri, C; Giacosa, A; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2021) |
| " This randomized controlled trial aims to evaluate the efficacy and safety of berberine in the treatment of patients with polycystic ovary syndrome." | 5.22 | The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial. ( Chai, QY; Liu, JP; Ma, HL; Sun, J; Wu, XK; Zhang, K; Zhang, Y; Zhang, YJ, 2016) |
| "To study whether a combination of berberine and letrozole results in higher live births than letrozole alone in infertile women with polycystic ovary syndrome (PCOS)." | 5.22 | Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. ( Liang, RN; Liu, JP; Ma, HX; Ng, EH; Shao, XG; Wang, YY; Wu, XK; Xue, HY, 2016) |
| "Berberine and metformin treatments prior to IVF improved the pregnancy outcome by normalizing the clinical, endocrine and metabolic parameters in PCOS women." | 5.19 | The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. ( An, Y; Guan, Y; Liu, B; Lu, M; Sun, Z; Zhang, Y, 2014) |
| "We postulate that women with PCOS will have improved insulin resistance following berberine administration." | 5.17 | Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial. ( Hou, L; Kuang, H; Li, Y; Ma, H; Ng, EH; Wu, X; Zhang, Y, 2013) |
| "Ours is the first study to report that for women with PCOS, myo-inositol combined with D-chiro-inositol and metformin combined with thiazolidinediones appear superior to metformin alone in improving insulin resistance and decreasing total testosterone." | 5.12 | Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. ( He, B; Xing, C; Zhang, J; Zhao, H, 2021) |
| "The aim of this study was to investigate the effects of berberine on polycystic ovary syndrome (PCOS) with insulin resistance (IR)." | 4.02 | Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites. ( Li, XL; Shen, HR; Xu, X; Ye, D, 2021) |
| "To study the role of selected serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome (PCOS)." | 3.96 | The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. ( Ai, W; Duan, Y; Kuang, H; Li, D; Li, M; Li, W; Liu, S; Liu, X; Shao, M; Wang, Y; Xu, Y, 2020) |
| "Berberine has been found to exhibit an array of pharmacological activities relating to the lowering of blood glucose and the treatment of polycystic ovarian syndrome (PCOS)." | 3.96 | Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways. ( Fang, J; Li, F; Liu, X; Liu, Z; Shan, Y; Wang, Y; Zhang, N; Zhao, H; Zhuang, L, 2020) |
| "To evaluate the effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome." | 3.81 | A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome. ( Chen, X; Li, C; Li, L; Ng, EH; Pan, P; Wu, X; Yang, D, 2015) |
| " In this study, the serum samples of 15 overweight PCOS patients before and after treatment with berberine for three months were collected for clinic biochemical test and metabolomic research." | 3.80 | [Application of metabolomics in treating polycystic ovary syndrome with berberine based on ultra high performance liquid chromatography-mass spectrometry]. ( Hou, L; Li, Y; Xu, G; Zhang, C; Zhang, H; Zhao, X, 2014) |
| "Theca cells with dexamethasone-induced insulin resistance showed defective glucose uptake and excessive testosterone production, both of which were effectively antagonized by berberine." | 3.77 | Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. ( Baillargeon, JP; Han, F; Hou, L; Kuang, H; Li, W; Wang, Y; Wu, X; Zhao, L, 2011) |
| "To investigate the functional and metabolic alterations in cultured insulin resistant ovary model in vitro, and to observe the effect of berberine (Ber, a Chinese medical monomer) in improving insulin resistance (IR)." | 3.76 | [Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary]. ( Li, W; Liu, YC; Wang, XX, 2010) |
| "Berberine (BBR) is an isoquinoline derivative alkaloid extracted from Chinese medicinal herbs that has been used as an insulin sensitizer." | 2.77 | A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. ( Deng, H; Guan, Y; Liang, K; Ma, Y; Sui, M; Wang, A; Wei, W; Zhang, H; Zhang, Y; Zhao, H, 2012) |
| " In conclusion, the use of berberine for PCOS is safe and promising, even if more studies are needed to create a consensus about the dosage of berberine useful for long-term therapy." | 2.66 | Polycystic ovary syndrome management: a review of the possible amazing role of berberine. ( Faliva, MA; Gasparri, C; Infantino, V; Naso, M; Nichetti, M; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M; Spadaccini, D, 2020) |
| "Berberine is a monomer from Chinese herbs such as Coptis chinensis, whose effect on improving ovulation and endometrial receptivity of PCOS is uncertain." | 1.62 | Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. ( Dong, H; Nie, K; Su, H; Tang, Y; Wang, H; Wang, Z; Xu, X, 2021) |
| "Berberine (BBR) has many pharmacological properties and is used as an insulin sensitizer." | 1.62 | Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis. ( Li, XL; Shen, HR; Xu, X, 2021) |
| "Berberine is an isoquinoline plant alkaloid with numerous biological activities, and it was testified to improve some diseases related to PCOS in animal models and in humans." | 1.43 | Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome. ( Fu, X; Kuang, H; Wang, Q; Wang, Y; Xu, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 13 (52.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, HR | 2 |
| Xu, X | 3 |
| Ye, D | 1 |
| Li, XL | 2 |
| Rondanelli, M | 2 |
| Riva, A | 2 |
| Petrangolini, G | 2 |
| Allegrini, P | 1 |
| Giacosa, A | 1 |
| Fazia, T | 1 |
| Bernardinelli, L | 1 |
| Gasparri, C | 2 |
| Peroni, G | 2 |
| Perna, S | 2 |
| Miao, X | 1 |
| Cui, W | 1 |
| Xia, Q | 1 |
| Wang, W | 1 |
| Liu, Z | 2 |
| Xiao, J | 1 |
| Qiao, C | 1 |
| Zhao, Y | 1 |
| Li, B | 1 |
| Liu, Y | 1 |
| Peng, Y | 1 |
| Yang, X | 1 |
| Shi, J | 1 |
| Gao, X | 1 |
| Wang, D | 1 |
| Zhang, N | 1 |
| Liu, X | 3 |
| Zhuang, L | 1 |
| Zhao, H | 3 |
| Shan, Y | 1 |
| Li, F | 1 |
| Wang, Y | 4 |
| Fang, J | 1 |
| Infantino, V | 1 |
| Faliva, MA | 1 |
| Naso, M | 1 |
| Nichetti, M | 1 |
| Spadaccini, D | 1 |
| Kuang, H | 4 |
| Duan, Y | 1 |
| Li, D | 1 |
| Xu, Y | 1 |
| Ai, W | 1 |
| Li, W | 3 |
| Liu, S | 1 |
| Li, M | 1 |
| Shao, M | 1 |
| Mirzaee, F | 1 |
| Razmjouei, P | 1 |
| Shahrahmani, H | 1 |
| Vafisani, F | 1 |
| Najaf Najafi, M | 1 |
| Ghazanfarpour, M | 1 |
| Yu, J | 1 |
| Ding, C | 1 |
| Hua, Z | 1 |
| Jiang, X | 1 |
| Wang, C | 1 |
| Zhang, SW | 1 |
| Zhou, J | 1 |
| Gober, HJ | 1 |
| Leung, WT | 1 |
| Wang, L | 1 |
| Wang, Z | 1 |
| Nie, K | 1 |
| Su, H | 1 |
| Tang, Y | 1 |
| Wang, H | 1 |
| Dong, H | 1 |
| Xing, C | 1 |
| Zhang, J | 1 |
| He, B | 1 |
| Ong, M | 1 |
| Peng, J | 1 |
| Jin, X | 1 |
| Qu, X | 1 |
| Li, Y | 2 |
| Ma, H | 1 |
| Zhang, Y | 4 |
| Ng, EH | 3 |
| Hou, L | 3 |
| Wu, X | 3 |
| An, Y | 1 |
| Sun, Z | 1 |
| Liu, B | 1 |
| Guan, Y | 2 |
| Lu, M | 1 |
| Cicero, AF | 1 |
| Reggi, A | 1 |
| Parini, A | 1 |
| Morbini, M | 1 |
| Rosticci, M | 1 |
| Grandi, E | 1 |
| Borghi, C | 1 |
| Zhang, C | 1 |
| Zhang, H | 2 |
| Zhao, X | 1 |
| Xu, G | 1 |
| Li, L | 1 |
| Li, C | 1 |
| Pan, P | 1 |
| Chen, X | 1 |
| Yang, D | 1 |
| Fu, X | 1 |
| Xu, J | 1 |
| Wang, Q | 1 |
| Wu, XK | 2 |
| Wang, YY | 1 |
| Liu, JP | 2 |
| Liang, RN | 1 |
| Xue, HY | 1 |
| Ma, HX | 1 |
| Shao, XG | 1 |
| Sun, J | 1 |
| Zhang, YJ | 1 |
| Chai, QY | 1 |
| Zhang, K | 1 |
| Ma, HL | 1 |
| Wang, XX | 1 |
| Liu, YC | 1 |
| Zhao, L | 1 |
| Han, F | 1 |
| Baillargeon, JP | 1 |
| Wei, W | 1 |
| Wang, A | 1 |
| Sui, M | 1 |
| Liang, K | 1 |
| Deng, H | 1 |
| Ma, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS[NCT01138930] | 120 participants (Anticipated) | Interventional | 2010-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for berberine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties.
Topics: Anti-Inflammatory Agents; Berberine; Female; Humans; Polycystic Ovary Syndrome; Pregnancy; Pregnancy | 2023 |
Polycystic ovary syndrome management: a review of the possible amazing role of berberine.
Topics: Adult; Berberine; Female; Humans; Polycystic Ovary Syndrome; Pregnancy | 2020 |
The effect and safety of Berberine on polycystic ovary syndrome: a systematic review.
Topics: Adult; Androstenedione; Berberine; Body Mass Index; Female; Follicle Stimulating Hormone; Humans; In | 2021 |
Effect and mechanism of berberine against polycystic ovary syndrome.
Topics: Animals; Berberine; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrom | 2021 |
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Topics: Berberine; Clinical Decision-Making; Female; Humans; Hypoglycemic Agents; Inositol; Insulin; Insulin | 2021 |
Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Topics: Androgens; Berberine; Drugs, Chinese Herbal; Female; Ginsenosides; Glucosides; Humans; Insulin Resis | 2017 |
7 trials available for berberine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study.
Topics: Adult; Berberine; Body Composition; Endpoint Determination; Female; Hormones; Humans; Inflammation; | 2021 |
Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Berberine; Biomarkers; Blood Glucose; China; Clinical Proto | 2013 |
The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
Topics: Adult; Berberine; Female; Fertilization in Vitro; Humans; Hypoglycemic Agents; Infertility, Female; | 2014 |
Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Berberine; Cardiovascular Diseases; Contraception; Contraceptives, | 2014 |
Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Berberine; China; Double-Blind Method; Drug Administration Schedule; Dr | 2016 |
The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Berberine; Clinical Protocols; Data Interpretation, Statistical; Drugs, Chinese H | 2016 |
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
Topics: Berberine; Cholesterol; Cholesterol, LDL; Female; Humans; Insulin Resistance; Metformin; Polycystic | 2012 |
12 other studies available for berberine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites.
Topics: Animals; Berberine; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Female; Gastrointestinal Micr | 2021 |
Berberine alleviates LPS-induced apoptosis, oxidation, and skewed lineages during mouse preimplantation development†.
Topics: Animals; Apoptosis; Berberine; Cell Lineage; Female; Humans; Lipopolysaccharides; Mammals; Mice; Pol | 2022 |
Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.
Topics: Animals; Berberine; DNA-Binding Proteins; Female; Insulin Resistance; Mitogen-Activated Protein Kina | 2020 |
The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
Topics: Adult; Anti-Inflammatory Agents; Anti-Mullerian Hormone; Berberine; Cells, Cultured; Female; Glycoli | 2020 |
Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
Topics: Animals; Apoptosis; Berberine; Diet, High-Fat; Female; Gene Expression; Inflammation; Insulin Resist | 2021 |
Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
Topics: Animals; Berberine; Female; Humans; Insulin Resistance; Phosphatidylinositol 3-Kinases; Polycystic O | 2021 |
Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome.
Topics: Animals; Berberine; Endometrium; Female; Metformin; Ovulation; Polycystic Ovary Syndrome; Rats | 2021 |
[Application of metabolomics in treating polycystic ovary syndrome with berberine based on ultra high performance liquid chromatography-mass spectrometry].
Topics: Berberine; Chromatography, High Pressure Liquid; Discriminant Analysis; Female; Humans; Least-Square | 2014 |
A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Anovulation; Berberine; China; Female; Gonadal Steroid Hormones; Humans; Menstrua | 2015 |
Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome.
Topics: Antineoplastic Agents; Berberine; Female; High-Throughput Screening Assays; Humans; Molecular Dockin | 2016 |
[Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary].
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Berberine; Female; In Vitro Techniques; Insu | 2010 |
Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro.
Topics: Berberine; Cells, Cultured; Dexamethasone; Drug Interactions; Female; Glucocorticoids; Glucose; Huma | 2011 |